ITEM 8.01 Other Events.

On January 7, 2022, Intra-Cellular Therapies, Inc. (the "Company") issued a press release (the "Closing Press Release") announcing that it had closed its previously announced public offering of 9,523,810 shares of its common stock at a public offering price of $42.00 per share. The Company sold an aggregate of 10,952,381 shares of its common stock, including 1,428,571 additional shares which the underwriters exercised their option in full to purchase, with net proceeds to the Company of approximately $433.7 million, after deducting underwriting discounts and commissions and estimated offering expenses.

The Company's Closing Press Release is filed as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

ITEM 9.01 Financial Statements and Exhibits.




(d) Exhibits



Exhibit
Number       Description

99.1           Press Release of Intra-Cellular Therapies, Inc., dated January 7,
             2022.

104          Cover Page Interactive Data File (embedded within the Inline XBRL
             document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses